Genprex, Inc. (GNPX) Financials

GNPX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 16.6 million 4.3 million
2023-06-30 15.9 million 3.9 million
2023-03-31 23.3 million 4.8 million
2022-12-31 25.1 million 2.8 million

GNPX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.8 million 1.5 million
2023-06-30 -8.1 million 1.5 million
2023-03-31 -7.0 million 1.3 million
2022-12-31 -4.6 million 1.5 million

GNPX Net Income

No data available :(

GNPX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.7 million - -
2023-06-30 10.0 million - -
2023-03-31 18.1 million - -
2022-12-31 21.0 million - -

GNPX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 57.8 million
2023-06-30 52.0 million
2023-03-31 49.5 million
2022-12-31 47.1 million

GNPX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 21756 4.6 million 3.2 million -
2023-06-30 20000 4.0 million 4.1 million -
2023-03-31 19627 5.3 million 4.0 million -
2022-12-31 19998 3.3 million 3.5 million -

GNPX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 3724
2023-06-30 - 3837
2023-03-31 - 4016
2022-12-31 - 23.8 million

GNPX

Price: $2.50

52 week price:
2.12
46.00

Earnings Per Share: -22.56 USD

P/E Ratio: -0.18

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 159356

Market Capitalization: 5.1 million

Links: